CareTrust REIT Inc. (CTRE)vsWest Pharmaceutical Services Inc (WST)
CTRE
CareTrust REIT Inc.
$37.14
-0.83%
REAL ESTATE · Cap: $8.06B
WST
West Pharmaceutical Services Inc
$245.27
+1.60%
HEALTHCARE · Cap: $17.68B
Smart Verdict
WallStSmart Research — data-driven comparison
West Pharmaceutical Services Inc generates 545% more annual revenue ($3.07B vs $476.39M). CTRE leads profitability with a 67.3% profit margin vs 16.1%. CTRE appears more attractively valued with a PEG of 1.26. CTRE earns a higher WallStSmart Score of 76/100 (B+).
CTRE
Strong Buy76
out of 100
Grade: B+
WST
Buy55
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+41.5%
Fair Value
$67.39
Current Price
$37.14
$30.25 discount
Margin of Safety
-256.8%
Fair Value
$68.99
Current Price
$245.27
$176.28 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Keeps 67 of every $100 in revenue as profit
Strong operational efficiency at 67.1%
Revenue surging 55.1% year-over-year
Earnings expanding 77.1% YoY
Conservative balance sheet, low leverage
Reasonable price relative to book value
Safe zone — low bankruptcy risk
Strong operational efficiency at 21.6%
Areas to Watch
Moderate valuation
Weak financial health signals
Premium valuation, high expectations priced in
2.1% earnings growth
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : CTRE
The strongest argument for CTRE centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 67.3% and operating margin at 67.1%. Revenue growth of 55.1% demonstrates continued momentum.
Bull Case : WST
The strongest argument for WST centers on Altman Z-Score, Operating Margin. Profitability is solid with margins at 16.1% and operating margin at 21.6%.
Bear Case : CTRE
The primary concerns for CTRE are P/E Ratio, Piotroski F-Score.
Bear Case : WST
The primary concerns for WST are P/E Ratio, EPS Growth, PEG Ratio.
Key Dynamics to Monitor
CTRE profiles as a growth stock while WST is a mature play — different risk/reward profiles.
WST carries more volatility with a beta of 1.18 — expect wider price swings.
CTRE is growing revenue faster at 55.1% — sustainability is the question.
WST generates stronger free cash flow (175M), providing more financial flexibility.
Bottom Line
CTRE scores higher overall (76/100 vs 55/100), backed by strong 67.3% margins and 55.1% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
CareTrust REIT Inc.
REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA
CareTrust REIT, Inc. is a publicly traded, self-managed real estate investment trust engaged in the ownership, acquisition, development, and leasing of skilled nursing, senior housing, and other healthcare-related properties.
Visit Website →West Pharmaceutical Services Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.
Compare with Other REIT - HEALTHCARE FACILITIES Stocks
Want to dig deeper into these stocks?